raubasine has been researched along with papaverine in 2 studies
Studies (raubasine) | Trials (raubasine) | Recent Studies (post-2010) (raubasine) | Studies (papaverine) | Trials (papaverine) | Recent Studies (post-2010) (papaverine) |
---|---|---|---|---|---|
7 | 0 | 3 | 6,027 | 305 | 355 |
140 | 8 | 22 | 6,027 | 305 | 355 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benzi, G; Curti, D | 1 |
Brevetti, G; Chiariello, M; Condorelli, M; Desiderati, M; Spena, M; Verrienti, S | 1 |
2 other study(ies) available for raubasine and papaverine
Article | Year |
---|---|
Role of synaptosomal enzymatic alterations and drug treatment in brain aging.
Topics: Aging; Almitrine; Animals; Brain; Citrate (si)-Synthase; Electron Transport Complex IV; Glucosephosphate Dehydrogenase; Male; Papaverine; Phosphofructokinase-1; Pyruvate Dehydrogenase Complex; Rats; Rats, Inbred Strains; Secologanin Tryptamine Alkaloids; Synaptosomes; Yohimbine | 1990 |
Beneficial effect of papaverine plus raubasine in peripheral arterial insufficiency.
Topics: Aged; Arteriosclerosis; Blood Pressure; Drug Combinations; Heart Rate; Humans; Leg; Middle Aged; Papaverine; Perfusion; Secologanin Tryptamine Alkaloids; Vasoconstrictor Agents; Vasodilator Agents; Yohimbine | 1983 |